Consistent with this previous finding, siRNA-mediated depletion of ZRF1 did not alter the proliferative, migratory, or invasive capacities or the sensitivity to RA in neuroblastoma cells, thus confirming that ZRF1 is dispensable for the progression of this type of tumor. Here, DNAJC2 is linked to neuroblastoma.